G J Van Kamp
Overview
Explore the profile of G J Van Kamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pijnenburg Y, Schoonenboom S, Barkhof F, Knol D, Mulder C, Van Kamp G, et al.
J Neurol Neurosurg Psychiatry
. 2006 Jan;
77(2):246-8.
PMID: 16421130
In order to better understand the large variation in cerebrospinal fluid (CSF) tau and amyloid-beta(1-42) (Abeta42) in frontotemporal lobar degeneration (FTLD), relations between these biomarkers and clinical parameters, neuroimaging characteristics,...
2.
Schoonenboom S, Visser P, Mulder C, Lindeboom J, van Elk E, Van Kamp G, et al.
Neurocase
. 2005 Apr;
11(1):8-13.
PMID: 15804919
The aim of the study was to compare clinical variables between MCI patients at different risk for Alzheimer's disease (AD) according to their biomarker profile. Fifty-four percent out of 39...
3.
Zwemmer J, van Veen T, van Winsen L, Van Kamp G, Barkhof F, Polman C, et al.
Mult Scler
. 2004 Jun;
10(3):272-7.
PMID: 15222690
Background: Whereas a number of studies suggest that the ApoE polymorphism is not associated with disease susceptibility in multiple sclerosis (MS), results with regard to disease severity, however, are conflicting....
4.
Pijnenburg Y, Schoonenboom N, Rosso S, Mulder C, Van Kamp G, van Swieten J, et al.
Neurology
. 2004 May;
62(9):1649.
PMID: 15136709
No abstract available.
5.
Schoonenboom N, Pijnenburg Y, Mulder C, Rosso S, Van Elk E, Van Kamp G, et al.
Neurology
. 2004 May;
62(9):1580-4.
PMID: 15136685
Objective: To determine the diagnostic value of CSF amyloid beta(1-42) (Abeta42), CSF total tau, and CSF tau phosphorylated at threonine-181 (Ptau-181) in early-onset Alzheimer disease (EAD) vs frontotemporal lobar degeneration...
6.
Mulder C, Wahlund L, Teerlink T, Blomberg M, Veerhuis R, Van Kamp G, et al.
J Neural Transm (Vienna)
. 2003 Aug;
110(8):949-55.
PMID: 12898349
Choline containing phospholipids are essential for the integrity of the'cell'membrane. Minor changes in the lysophosphatidylcholine (lyso-PC)/phosphatidylcholine (PC) ratio may lead to neuronal damage and cell loss. Several studies have shown...
7.
Mulder C, Schoonenboom S, Wahlund L, Scheltens P, Van Kamp G, Veerhuis R, et al.
J Neural Transm (Vienna)
. 2002 Dec;
109(12):1491-8.
PMID: 12486489
Serum amyloid P component (SAP) and complement C1q are found highly co-localized with extracellular fibrillar amyloidbeta (Abeta) deposits in Alzheimer's disease (AD) brain. Conflicting data were reported earlier about the...
8.
Jongsma A, Piek J, Zweemer R, Verheijen R, Klein Gebbinck J, Van Kamp G, et al.
Mol Pathol
. 2002 Oct;
55(5):305-9.
PMID: 12354934
Background/aims: Loss of heterozygosity (LOH) on chromosome 13q has been reported to occur frequently in human ovarian cancer, and indications have been found that chromosome 13 may also play a...
9.
Mulder C, Wahlund L, Blomberg M, de Jong S, Van Kamp G, Scheltens P, et al.
J Neural Transm (Vienna)
. 2002 Aug;
109(9):1203-8.
PMID: 12203047
Nitric oxide (NO) may play a role in the pathophysiology of Alzheimer's disease (AD). Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is involved in regulation of NO production....
10.
Pluijm S, Dik M, Jonker C, Deeg D, Van Kamp G, Lips P
Osteoporos Int
. 2002 Aug;
13(9):701-9.
PMID: 12195533
The aim of this study was to examine whether the presence of apolipoprotein E epsilon4 (ApoE epsilon4) is associated with a lower bone mineral density (BMD), lower quantitative ultrasound (QUS)...